Real-Time Monitoring of Patient Centered Outcomes in English And Non-English-Speaking Patients Undergoing Radiation Treatment and its Impact on Overcoming Language Barriers

Study on Monitoring Symptoms During Cancer Treatment Using Surveys

J
Jordan Holmes

Primary Investigator

Recruiting
18 years - 100 years
All
Phase N/A
126 participants needed
4 Locations

Brief description of study

The purpose of this study is to evaluate if asking patients to complete surveys about their symptoms and quality of life during radiation treatment in real time improves management of symptoms and side effects commonly experienced during radiation treatment. 
 
Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:
IU Clinical Trials Office 
Phone: (317) 278-5632

Detailed description of study

Participants will be randomly put into one of two groups and will be in the study for about 10 months.

  • Researchers will collect information about medical history (such as cancer diagnosis, treatments received, and any other medical conditions etc.) and demographics (such as age, gender, ethnicity etc.) from medical records.
  • Researchers will collect information from clinic visits with treating physician during the study.
  • Participants will answer survey questions about symptoms they areexperiencing and their quality of life; surveys will be completed at the following timepoints:

1) within 2 weeks prior to the start of your radiation treatment

2) weekly during your radiation treatment

3) at the end of radiation treatment

4) at 1 month and 6 months after you complete radiation treatment

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Cancer, Radiation therapy
  • Age: 18 years - 100 years
  • Gender: All

Inclusion Criteria:
1.     Age≥ 18 at time of consent.
2.     Ability to provide written informed consent and HIPAA authorization.
3.     Patients must be English or Spanish speaking
4.     Pathologically proven diagnosis of endometrial, cervical, or prostate cancer.
5.     Planning to receive definitive or adjuvant radiation therapy (≥ 20 fractions of EBRT) (+/- chemotherapy or hormonal therapy) with curative intent as part of standard of care.

Exclusion Criteria:
1.     Patients taking part in other clinical trials involving the completion of extensive patient reported outcome or quality of life measures
2.     Patients exhibiting overt psychopathology/cognitive dysfunction in the opinion of the treating investigator and/or principal investigator.
3.     Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 3 years.
4.     Prior radiation to the pelvis
5.     Prior treatment with platinum-based chemotherapy that is outside of the current treatment window
6.     Prior exposure to hormonal treatment that is outside of the current treatment window

This study investigates how completing surveys about symptoms and quality of life during radiation treatment affects symptom management. The focus is on patients who speak English or Spanish and are undergoing treatment for certain cancers, like endometrial, cervical, or prostate cancer. The goal is to see if real-time feedback can improve care during radiation treatment, which uses high-energy rays to target cancer cells.

Participants will be divided into two study arms. They will provide medical history and demographic information, and answer surveys about their symptoms at specific times: before, during, and after radiation treatment. These surveys help researchers understand the patient's experience and quality of life during their treatment journey.

  • Who can participate: Adults 18 and older who speak English or Spanish and have been diagnosed with endometrial, cervical, or prostate cancer can participate. They must be planning to receive this type of cancer treatment and able to provide consent.
  • Study details: Participants will be assigned to one of two study arms and will need to complete surveys about their symptoms and quality of life at various times during and after their treatment. The study will collect information from medical records and clinic visits.
  • Study timelines: The study will last 10 months.
Updated on 23 Sep 2025. Study ID: CTO-IUSCCC-0765, 13393

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the Study Team